Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE PHARMA GROUP

15.37
-0.0300-0.19%
Volume:3K
Turnover:46.57K
Market Cap:1.43B
PE:-6.61
High:15.44
Open:15.32
Low:15.09
Close:15.40
52wk High:40.47
52wk Low:15.09
Shares:93.33M
Float Shares:71.58M
Volume Ratio:0.73
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3260
EPS(LYR):-1.9957
ROE:-236.63%
ROA:-28.04%
PB:17.28
PE(LYR):-7.70

Loading ...

Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026

GlobeNewswire
·
Apr 22

ASCENTAGE-B (06855) Has Multiple Studies Selected for 2026 ASCO Conference

Stock News
·
Apr 22

ASCENTAGE PHARMA GROUP Grants Restricted Share Units and Stock Options

Stock News
·
Apr 20

ASCENTAGE-B (06855) Unveils Four Preclinical Advances at 2026 AACR Annual Meeting, Highlighting Potential of Multiple Combination Therapies

Stock News
·
Apr 20

Beneath the Glossy Sales Figures: ASCENTAGE PHARMA GROUP's Profitability Crisis and Three Critical Risks

Deep News
·
Apr 17

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zimmer Biomet Holdings (ZBH) and Ascentage Pharma Group International Unsponsored ADR (AAPG)

TIPRANKS
·
Apr 13

Piper Sandler Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)

TIPRANKS
·
Apr 10

Ascentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer Says

MT Newswires Live
·
Mar 27

Stock Track | Ascentage Pharma Group Soars 8.56% Intraday on Positive Analyst Ratings

Stock Track
·
Mar 27

BTIG Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)

TIPRANKS
·
Mar 27

Sector Update: Health Care

MT Newswires Live
·
Mar 26

Ascentage Pharma's 2025 Loss Widens, Revenue Falls

MT Newswires Live
·
Mar 26

ASCENTAGE-B Reports Strong Growth Driven by Dual Commercial Engines

Stock News
·
Mar 26

Press Release: Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

Dow Jones
·
Mar 26